Loading company…
NuChem Sciences provides drug discovery and preclinical research services to biotechnology and pharmaceutical companies.
NuChem Sciences supports small molecule drug discovery, helping biotechnology and pharmaceutical companies identify and optimize preclinical candidates. Its services include chemistry, biology, pharmacology, DMPK, consulting, and integrated drug discovery. Founded in 2011, the company is based in Saint-Laurent, Quebec, and its CEO was Marc Lebel as of May 2022. Fonds de solidarité FTQ invested in the company in October 2022; the investment was intended to help it acquire IniXium.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in